Results 231 to 240 of about 2,811,792 (409)

Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization

ESC Heart Failure, Volume 12, Issue 2, Page 1227-1236, April 2025.
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch, Ali Zafari, Shofiqul Islam, Shun Fu Lee, Rajiv Sankaranarayanan, Stephen J Greene, Mamas A Mamas, Ambarish Pandey, Harriette GC Van Spall   +8 more
wiley   +1 more source

Angiotensin receptor-neprilysin inhibitor treatment in people with chronic obstructive pulmonary disease and heart failure. [PDF]

Commun Med (Lond)
Hsu WH, Shiau BW, Wu JY, Chuang MH, Tsai YW, Huang PY, Hu KC, Hsu W, Liu TH, Liao KM, Lai CC.   +10 more
europepmc   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Use of Angiotensin Receptor Blockers in Celiac Disease Associated with Worse Outcomes. [PDF]

Dig Dis Sci
Hujoel IA, Hujoel MLA.
europepmc   +1 more source

Estimated plasma volume in heart failure with reduced ejection fraction: ACE inhibitors versus angiotensin receptor/neprilysin inhibitor in follow up [PDF]

S Varga, Luka Antolković, Ivan Zeljković, Nikola Pavlović, Ana Jordán, Marin Pavlov, Petra Vitlov, Diana Rudan, A Novák, Petar Lišnjić, Šime Manola, Ivana Jurin   +11 more
openalex   +1 more source

Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology.

HYPERTENSION, 2018
S. Eguchi, Tatsuo Kawai, R. Scalia, V. Rizzo   +3 more
semanticscholar   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger, Elric Zweck, Constanze Moos, Patrick Horn, Fabian Voß, Heinz‐Peter Schultheiss, Jacob Eifer Møller, Udo Boeken, Hug Aubin, Artur Lichtenberg, Malte Kelm, Michael Roden, Amin Polzin, Ralf Westenfeld, Julia Szendroedi, Daniel Scheiber   +15 more
wiley   +1 more source

Direct Renin Inhibition With Aliskiren Compared to Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Hypertension: A Systematic Review. [PDF]

Cureus
Gapizov A, Mohammad A, Singla S, Singla B, Kumawat S, Ajay, Ali Z.   +6 more
europepmc   +1 more source

Role of adipocyte angiotensinogen or angiotensin type 1a receptors in the development of diet-induced atherosclerosis or angiotensin II-induced abdominal aortic aneurysms [PDF]

Yasir Alsiraj, Kelly Putnam, Victoria English, Mark Ensor, Lisa A. Cassis   +4 more
openalex   +1 more source

Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate–salt hypertension [PDF]

, 2016
Mikako Hisamichi, Atsuko Kamijo‐Ikemori, Takeshi Sugaya, Daisuke Ichikawa, Takayuki Natsuki, Seiko Hoshino, Kenjiro Kimura, Yugo Shibagaki   +7 more
openalex   +1 more source